FR EN MAIN NAVIGATION COMPANY SCIENCE PRODUCTS PARTNERING INVESTORS MEDIA CAREERS OUR HISTORY Home Company Our history 2020 First Innate asset progressing to Phase 3 - monalizumab partnered with AstraZeneca 2019 Listing on the Nasdaq 2018 Multi-term agreement with AstraZeneca Selection of IPH5201 as development candidate Clinical trial collaboration with AstraZeneca on avdoralimab (IPH5401) Eric Vivier appointed Chief Scientific Officer 2017 Acquisition of anti-C5aR (IPH5401 now avdoralimab) from Novo Nordisk A/S 2016 Key leadership and corporate governance changes: Mondher Mahjoubi appointed Chief Executive Officer and Chairman of the Executive Board ; Hervé Brailly, co-founder of the Company appointed Chairman of the Supervisory Board New CD73 checkpoint inhibitor program (IPH53) Research collaboration and licensing agreement on NK cell engagers with Sanofi 2015 Co-development and commercialization agreement with AstraZeneca on monalizumab Start of Phase 1 trial for lacutamab (IPH4102) 2011 Collaboration and licensing agreement with Bristol-Myers Squibb on lirilumab Initiation of Phase 1 clinical trials with IPH2201 (monalizumab) by Novo Nordisk A/S 2006 Enlarging of the collaboration and licensing agreement with Novo Nordisk A/S Initial Public Offering (“IPO”) on the NYSE-Euronext Paris 2003 First collaboration and licensing deal with Novo Nordisk A/S for the development of an anti-KIR antibody program, potentiating NK cells activation against tumors 1999 Company inception Founders Innate Pharma was founded in 1999 by a group of immunologists, four European Scientists - pioneers in the field of innate immunity (Alessandro Moretta, Marc Bonneville, Jean-Jacques Fournié and Eric Vivier) - and two managers from the biopharmaceutical industry (Hervé Brailly and François Romagné). From left to right: Hervé BRAILLY, PhD Eric VIVIER, DVM, PhD Marc Bonneville, DVM, PhD Alessandro MORETTA, MD, PhD Jean-Jacques FOURNIÉ, PhD François ROMAGNÉ, PhD Main menu Company profile Management Leadership Team Supervisory Board Strategic Advisory Board Our history Great Place to Work Footer Contact Location Legal Info Terms of use Privacy Notice Cookies notice General Conditions of Purchase Search Search Follow us Stay in touch Subscribe to our newsletter Contact us Location 117, Avenue de Luminy - BP 30191 13 009 Marseille FRANCE +33 (0)4 30 30 30 30 Innate Pharma, Inc. 2273 Research Boulevard, Suite 350 Rockville, MD 20850, USA